The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants

This publication has 16 references indexed in Scilit:

• Th1/Th2 cells
  Inflammatory Bowel Diseases, 2007
• CpG DNA is an effective oral adjuvant to protein antigens in mice
  Vaccine, 2000
• Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants
  Vaccine, 2000
• CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans
  Vaccine, 2000
• CpG DNA induces stronger immune responses with less toxicity than other adjuvants
  Vaccine, 2000
• The paradigm of Th1 and Th2 cytokines
  Immunologic Research, 1999
• CpG DNA as mucosal adjuvant
  Vaccine, 1999
• CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.
  Proceedings of the National Academy of Sciences, 1996
• Bacterial DNA Induces Murine Interferon-γ Production by Stimulation of Interleukin-12 and Tumor Necrosis Factor-α
  Cellular Immunology, 1996
• CpG motifs in bacterial DNA trigger direct B-cell activation
  Nature, 1995